Recombinant Hydra vulgaris Pedin

Shipped with Ice Packs
In Stock

Description

Structure and Sequence

Recombinant Hydra vulgaris Pedin (also referred to as Pedibin in some sources) is a synthetic version of a naturally occurring peptide isolated from Hydra vulgaris. Key structural details include:

AttributeValue
Amino Acid Length21 residues
SequenceAGEDVSHELEEKEKALANHS E
Source OrganismHydra vulgaris (strain Zurich)
Expression HostE. coli

The peptide lacks significant homology to known proteins, suggesting a unique evolutionary origin .

Bioactivity and Function

Pedin exhibits potent morphogenetic activity, specifically accelerating foot regeneration in Hydra polyps. Its bioactivity is mediated through the "foot-activating potential", a signaling pathway critical for orchestrating regeneration . Functional studies reveal:

  • Regeneration Role: Pedin stimulates foot-specific differentiation by enhancing cell proliferation and patterning at injury sites .

  • Mechanism: Likely involves modulation of the Wnt/β-catenin pathway, a key regulator of axial patterning during regeneration .

3.1. Isolation and Characterization

Pedin was first isolated in 1996 from Hydra vulgaris using bioassays that measured foot regeneration rates. It was identified as a 13-amino acid peptide (shorter variant) with no homology to existing proteins . Subsequent recombinant production yielded a 21-amino acid variant (Pedibin), which retains bioactivity .

3.2. Applications in Regeneration Studies

Pedin has been used to investigate:

  • Extracellular Vesicle (EV) Signaling: Pedin-like peptides are packaged into EVs, which modulate head and foot regeneration in Hydra .

  • Tissue Engineering: Its ability to direct cell fate suggests potential in designing regenerative therapies .

3.3. Comparative Analysis

FeaturePedin (13-mer)Pedibin (21-mer)
SequenceNot explicitly publishedAGEDVSHELEEKEKALANHS E
SourceNative Hydra tissueRecombinant E. coli
FunctionFoot-specific activationEquivalent bioactivity

Product Specs

Form
Lyophilized powder. We will ship the in-stock format unless you specify a format preference when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. Proteins are shipped with blue ice packs by default. Dry ice shipping is available upon request for an additional fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
Pedin
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-13
Protein Length
Cytoplasmic domain
Purity
>85% (SDS-PAGE)
Species
Hydra vulgaris (Hydra) (Hydra attenuata)
Target Protein Sequence
EELRPEVLPD VSE
Uniprot No.

Target Background

Function
Morphogenetically active peptide involved in foot development.

Q&A

What is Pedin and what is its biological significance in Hydra vulgaris?

Pedin is a 13-amino acid peptide isolated from Hydra vulgaris that stimulates foot-specific differentiation, measured experimentally as an acceleration of foot regeneration . This peptide was first characterized in 1996 alongside a related 21-amino acid peptide, both showing morphogenetic properties. Pedin is considered a major component of the 'foot-activating potential' in hydra developmental processes . The peptide's sequence bears no significant homology to other known peptides or proteins, suggesting it represents a unique signaling molecule specific to cnidarian developmental processes .

Unlike structural proteins or enzymes, Pedin functions as a signaling molecule within the complex molecular network that regulates axial patterning and regeneration in Hydra. Its specificity to foot development makes it particularly valuable for studying tissue-specific differentiation mechanisms in simple metazoans.

How does Pedin relate to regenerative processes in different Hydra species?

Regenerative capabilities vary significantly between Hydra species, with most exhibiting robust whole-body regeneration while some (notably H. oligactis and other members of the Oligactis clade) consistently fail to regenerate their feet . Research indicates that foot regeneration in Hydra vulgaris requires activation of the Wnt signaling pathway, which appears to be deficient in the general injury response of H. oligactis .

Pedin's role in foot regeneration must be understood in this broader context of species-specific regenerative capabilities. In H. vulgaris, where Pedin was first characterized, the peptide likely acts downstream of or in concert with Wnt signaling to promote foot-specific cell differentiation. Transcriptional profiling has revealed dlx2 as a likely high-level regulator of foot regeneration dependent on Wnt signaling activation . The presence and activity of Pedin across different Hydra species could provide valuable insights into the evolutionary conservation of regenerative mechanisms.

What methodologies were used in the original isolation and characterization of Pedin?

The original isolation of Pedin employed a bioassay-guided fractionation approach using foot regeneration acceleration as the biological readout . Researchers isolated two peptides from Hydra vulgaris tissue extracts through a series of chromatographic separations, followed by activity testing of individual fractions. The purified peptides were characterized using:

  • Amino acid sequencing to determine the primary structure

  • Biological assays measuring acceleration of foot regeneration

  • Development of polyclonal antibodies against both peptides

  • Radioimmunoassays to detect and quantify the peptides in tissue

  • Localization studies using the generated antibodies

These approaches confirmed Pedin's 13-amino acid sequence and its biological activity in promoting foot-specific differentiation. The methodological workflow combined classical protein purification techniques with functional validation, establishing Pedin as a bona fide morphogenetic factor in Hydra development .

What expression systems are most effective for recombinant Pedin production?

Based on experience with similar small peptides, several expression systems can be considered for recombinant Pedin production:

Expression SystemAdvantagesChallengesYield Potential
E. coliCost-effective, rapid growth, well-established protocolsPotential improper folding, lack of post-translational modificationsHigh with optimization
Yeast (P. pastoris)Proper folding, secretion to mediumLonger production time, glycosylation differencesModerate to high
Baculovirus/insect cellsBetter folding, suitable for eukaryotic proteinsHigher cost, complex setupModerate
Cell-free synthesisRapid production, avoids cellular toxicityHigher cost, smaller scaleLow to moderate

For a small peptide like Pedin (13 amino acids), E. coli expression as a fusion protein is often most practical. The peptide can be fused to a larger carrier protein (e.g., GST, MBP, or SUMO) to enhance solubility and expression, with a specific protease cleavage site for subsequent release of the native peptide. For Pedin specifically, including a protease recognition sequence that can be cleaved by HRV 3C protease would be advantageous, as this enzyme works efficiently under various buffer conditions and at lower temperatures .

What purification strategy should be employed for recombinant Pedin?

A multi-step purification strategy for recombinant Pedin should include:

  • Initial capture: Affinity chromatography based on the fusion tag (e.g., GST, His-tag)

  • Fusion protein cleavage: Treatment with a specific protease (e.g., HRV 3C protease) under optimized conditions

  • Separation of released peptide: Reverse-phase HPLC or size exclusion chromatography

  • Final polishing: Ion exchange chromatography if needed

The purification conditions should be optimized using design of experiments (DOE) methodology similar to approaches used for HRV 3C protease, where factors like resin amount, incubation time, buffer composition, and additives are systematically varied . For maximum yield, consider these parameters:

  • Buffer conditions: Test phosphate, Tris, and HEPES buffers at pH 7.0-8.0

  • Salt concentration: 100-300 mM NaCl range

  • Stabilizing additives: 5-15% glycerol and 1-5 mM DTT

  • Temperature: Perform purification at 4°C to minimize degradation

Final peptide purity should be verified by mass spectrometry and analytical HPLC, with biological activity confirmed using appropriate foot regeneration assays.

How can researchers verify the correct structure and folding of recombinant Pedin?

Verification of recombinant Pedin structure requires multiple complementary approaches:

  • Mass spectrometry analysis: Electrospray ionization (ESI-MS) or MALDI-TOF to confirm the exact molecular weight matching the theoretical mass of the 13-amino acid sequence.

  • Circular dichroism (CD) spectroscopy: While small peptides often lack defined secondary structure in solution, CD can confirm if recombinant Pedin adopts any characteristic conformations similar to the native peptide.

  • NMR spectroscopy: For detailed structural analysis, especially to determine if specific residues are involved in intramolecular interactions.

  • Biological activity assays: Most critically, functional validation through comparative testing with native Pedin in foot regeneration acceleration assays.

  • Antibody recognition: Using polyclonal antibodies raised against native Pedin to confirm immunological equivalence .

The active conformation of Pedin likely depends on specific intramolecular interactions that must be preserved in the recombinant version. Comparing activity between native and recombinant forms provides the most definitive validation of proper structure.

What controls are essential when designing experiments with recombinant Pedin?

Robust experimental design for recombinant Pedin studies requires multiple controls:

Control TypePurposeImplementation
Negative ControlEstablish baselineBuffer-only treatment or inactive peptide with similar physicochemical properties
Positive ControlValidate assay functionalityNative Pedin isolated from Hydra vulgaris tissue
Scrambled Peptide ControlTest sequence specificitySame amino acid composition with randomized sequence
Dose-Response ControlEstablish relationship between concentration and effectSerial dilutions of recombinant Pedin (typically 0.1-100 nM)
Time Course ControlDetermine temporal dynamicsFixed concentration with varying exposure times
Specificity ControlConfirm tissue/process specificityTest effect on non-foot tissues or processes
Antibody NeutralizationValidate mechanismPre-incubation with anti-Pedin antibodies to block activity

When testing biological activity in foot regeneration assays, variables like animal size, regeneration stage, and environmental conditions must be standardized across experiments. Statistical analysis should employ appropriate tests (typically ANOVA with post-hoc comparisons) with sufficient biological replicates (n≥10 per condition) to account for natural variation in regeneration rates.

How should researchers approach comparative studies between Pedin and the related 21-amino acid peptide?

The 21-amino acid peptide isolated alongside Pedin also stimulates foot-specific differentiation but may function through distinct or overlapping mechanisms . A comprehensive comparative study should:

  • Characterize binding profiles: Identify potential receptors or binding partners for both peptides using techniques like pull-down assays, surface plasmon resonance, or yeast two-hybrid screening.

  • Compare dose-response relationships: Determine EC50 values for both peptides in standardized foot regeneration assays under identical conditions.

  • Perform competition assays: Test whether pre-treatment with one peptide affects the activity of the other, suggesting shared or distinct receptors/mechanisms.

  • Conduct transcriptional profiling: Compare gene expression changes induced by each peptide using RNA-seq or qPCR focusing on known foot development markers.

  • Analyze temporal activation patterns: Determine if the peptides act during different temporal windows of the regeneration process.

  • Investigate structural relationships: Compare 3D structures (if determinable) to identify potential shared functional domains despite sequence differences.

  • Test cross-reactivity with antibodies: Determine if antibodies raised against one peptide recognize the other.

This systematic approach will help elucidate whether these peptides represent redundant systems, act synergistically, or regulate distinct aspects of foot morphogenesis in Hydra.

What assays provide the most reliable quantification of Pedin biological activity?

Several complementary assays can quantify Pedin's biological activity:

  • Foot regeneration acceleration assay: The gold standard, measuring time to complete foot regeneration in decapitated Hydra treated with recombinant Pedin compared to controls. This assay directly reflects the identified biological function of Pedin .

  • Molecular marker expression: Quantifying expression of foot-specific genes (e.g., dlx2) using qPCR or in situ hybridization following Pedin treatment .

  • Cell differentiation assays: Tracking the differentiation of specific cell types associated with foot formation using immunohistochemistry with cell-type-specific markers.

  • Pathway activation reporters: Using transgenic Hydra lines expressing fluorescent reporters downstream of relevant signaling pathways (particularly Wnt signaling) to visualize pathway activation in response to Pedin .

  • Calcium imaging: Monitoring calcium flux in Hydra tissues following Pedin application, as many morphogenetic signals trigger calcium signaling.

The foot regeneration acceleration assay remains most definitive, but molecular approaches provide mechanistic insights and are less subjective. A combination of functional and molecular readouts provides the most comprehensive assessment of Pedin activity.

How does Pedin interact with the Wnt signaling pathway in foot regeneration?

The relationship between Pedin and Wnt signaling in foot regeneration represents a critical research question based on recent findings. Wnt signaling has been identified as essential for foot regeneration in Hydra vulgaris, and its absence correlates with regeneration failure in H. oligactis . Potential experimental approaches to investigate the Pedin-Wnt relationship include:

  • Epistasis experiments: Apply Pedin following Wnt pathway inhibition (using small molecule inhibitors like IWP-2 or IWR-1) to determine if Pedin can rescue foot regeneration in the absence of Wnt signaling.

  • Transcriptional profiling: Compare gene expression profiles after Pedin treatment with and without Wnt pathway activation to identify shared downstream targets.

  • Biochemical interaction studies: Test for direct interactions between Pedin and Wnt pathway components using co-immunoprecipitation or proximity ligation assays.

  • Rescue experiments in H. oligactis: Test whether recombinant Pedin can rescue foot regeneration in H. oligactis, which lacks normal Wnt activation during regeneration .

  • Analysis of dlx2 regulation: Investigate whether Pedin treatment affects expression of dlx2, a likely high-level regulator of foot regeneration dependent on Wnt signaling .

Evidence suggests Pedin may function either downstream of Wnt signaling or in a parallel pathway that converges on similar developmental outcomes. Understanding this relationship would significantly advance our knowledge of regeneration mechanisms in Hydra.

How can recombinant Pedin be used to study evolutionary conservation of regeneration mechanisms?

Recombinant Pedin offers a powerful tool for comparative evolutionary studies of regeneration across cnidarian species. Research approaches could include:

  • Cross-species activity testing: Apply recombinant H. vulgaris Pedin to other Hydra species, particularly those with deficient foot regeneration like H. oligactis, to test for conservation of response mechanisms .

  • Sequence homology searches: Identify potential Pedin homologs in other cnidarians and test synthesized variants for functional conservation.

  • Receptor conservation analysis: Use labeled recombinant Pedin to identify receptors in H. vulgaris, then search for homologous receptors in related species.

  • Transcriptional response comparison: Compare transcriptional responses to Pedin treatment across species to identify conserved and divergent downstream pathways.

  • Genetic rescue experiments: Attempt to rescue foot regeneration in regeneration-deficient species through genetic introduction of Pedin expression constructs.

These approaches could reveal how regenerative mechanisms have evolved across the cnidarian lineage and potentially identify the molecular basis for species-specific differences in regenerative capacity. The unique evolutionary position of Hydra as a relatively simple metazoan with remarkable regenerative abilities makes this research particularly valuable for understanding the evolution of tissue plasticity.

What are the technical challenges in studying Pedin-receptor interactions?

Identifying and characterizing Pedin receptors presents several technical challenges:

  • Receptor identification: Small peptide ligands like Pedin often interact with G-protein coupled receptors (GPCRs) or receptor tyrosine kinases (RTKs), which can be difficult to isolate due to their membrane localization and potentially low abundance.

  • Binding affinity determination: Techniques like surface plasmon resonance (SPR) require purified receptor proteins, which can be challenging to produce in functional form.

  • Functional validation: Confirming that identified interactions are biologically relevant requires specialized assays in Hydra cells or tissues.

  • Limited genetic tools: While improving, genetic manipulation in Hydra remains more challenging than in model organisms like Drosophila or zebrafish.

Recommended approaches include:

  • Photoaffinity labeling with modified Pedin to capture interacting proteins

  • Expression cloning approaches using Hydra cDNA libraries

  • Comparative proteomic analysis of membrane fractions from Pedin-responsive and non-responsive tissues

  • Heterologous expression of candidate Hydra receptors in mammalian cell lines for binding studies

Understanding Pedin-receptor interactions would significantly advance our knowledge of the molecular mechanisms underlying tissue-specific differentiation signals in Hydra and potentially reveal conserved signaling pathways relevant to regeneration across metazoans.

How can structural biology approaches enhance our understanding of Pedin function?

Structural biology approaches can provide critical insights into Pedin's function despite challenges presented by its small size:

  • NMR structure determination: The 13-amino acid size of Pedin makes it ideal for solution NMR studies to determine its three-dimensional structure in different environments.

  • Structure-activity relationship (SAR) studies: Systematic alanine scanning or other amino acid substitutions can identify critical residues for bioactivity.

  • Molecular dynamics simulations: Computational approaches can predict how Pedin interacts with membranes or potential binding partners.

  • Co-crystallization attempts: If potential binding partners are identified, co-crystallization could reveal the molecular basis for interaction.

  • Conformational studies: Examining how Pedin's structure changes in different solutions (pH, ionic strength, lipid environments) may reveal functionally relevant conformational states.

These approaches can guide the design of Pedin analogs with enhanced stability or activity, potential antagonists for functional studies, and imaging probes for localization experiments. Understanding the structure-function relationship of Pedin would also facilitate comparative analyses with other morphogens operating in regeneration contexts.

What are common pitfalls in recombinant Pedin production and how can they be addressed?

Researchers frequently encounter several challenges when working with recombinant Pedin:

ChallengePotential CausesSolutions
Low expression yieldPeptide toxicity to host cells, codon usage biasUse inducible systems, optimize codons for expression host, express as fusion protein
Improper foldingOxidizing conditions, improper disulfide formationTest reduced/oxidized forms, optimize redox conditions during purification
AggregationHydrophobic interactions, concentration effectsInclude solubilizing agents (e.g., low concentrations of detergents), optimize buffer conditions
Proteolytic degradationHost proteases, sample handlingAdd protease inhibitors, minimize handling time, maintain cold temperatures
Activity loss during purificationDenaturation, oxidation, adsorption to surfacesTest activity at each purification step, use low-binding materials, include stabilizing agents

Optimization strategies should follow approaches similar to those used for HRV 3C protease purification, where factors such as buffer composition, additives, pH, and temperature are systematically varied and optimized . Activity assays should be performed throughout the purification process to track retention of biological function.

How should contradictory experimental results with recombinant Pedin be interpreted and resolved?

When facing contradictory results in Pedin research, implement this systematic troubleshooting approach:

  • Verify peptide integrity: Re-analyze peptide by mass spectrometry and HPLC to confirm identity, purity, and absence of degradation.

  • Check experimental variables: Systematically review all experimental conditions including:

    • Hydra strain and age consistency

    • Culture conditions (temperature, medium composition)

    • Regeneration stage uniformity

    • Peptide concentration accuracy

    • Reagent quality and freshness

  • Perform positive control validation: Use native Pedin or well-characterized batches of recombinant Pedin as positive controls.

  • Consider biological variability: Increase sample sizes to account for natural variation in regeneration responses.

  • Test batch-to-batch variation: Compare multiple independent preparations of recombinant Pedin.

  • Examine alternative readouts: If foot regeneration assays yield inconsistent results, use molecular markers or other readouts of Pedin activity.

  • Collaborate on blind testing: Have independent laboratories test the same Pedin preparations using standardized protocols.

Contradictory results often reflect subtle but important variables in biological systems and can lead to new insights about context-dependent activity or previously unrecognized cofactors required for Pedin function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.